Clinical trials
Technology clinical trials
Below are recruiting technology clinical trials, each written for real people, not researchers. We’re tracking 1,080 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06040242Recruiting
Exercise and heart rhythm study for ARVC patients
This study looks at how exercise affects heart rhythm in people with ARVC, a genetic heart condition. Participation involves supervised exercise sessions and heart monitoring to better understand safe activity levels.
Zurich, Canton of ZurichAges 14 years+ - NCT06005870RecruitingPhase 2
Zanubrutinib with R-CHOP for newly diagnosed p53-positive DLBCL
This trial tests a new combination: zanubrutinib (a targeted pill) plus standard chemotherapy (R-CHOP) for people newly diagnosed with DLBCL whose cancer cells have high p53 protein levels. The goal is to see if adding this drug helps shrink tumors better than chemotherapy alone.
Wuhan, HubeiAges 18–75 - NCT06007755Recruiting
Finding blood markers for confusion after heart surgery
This study is looking for certain substances in the blood that may show up if a person becomes confused or delirious after heart surgery. The goal is to find early warning signs so doctors can help prevent or treat this confusion.
Wuhan, HubeiAges 18 years+ - NCT05984147RecruitingPhase 1
Study of oral drug AUR108 for advanced lymphoma
This trial tests an experimental oral drug called AUR108 for people with advanced lymphoma that has come back after at least two prior treatments. The goal is to see if the drug is safe and if it can help shrink or control the lymphoma.
Visakhapatnam, Andhra PradeshAges 18–99 - NCT05989308Recruiting
MyChart Proxy Outreach to Parents Study
This study is testing a new way to help parents and guardians get access to their child's MyChart account. It sends an invitation directly through MyChart to make it easier to manage your child's health information online.
New Haven, ConnecticutAges 18 years+ - NCT05942859Enrolling by invitation
AI study using heart ECGs to spot pulmonary hypertension
This study looks at patterns on a 12-lead ECG (a common heart tracing) to help diagnose pulmonary hypertension, using results from a right heart catheter test. It may help doctors use ECGs better in the future, without changing your current care.
BathAges 18 years+ - NCT05917977Recruiting
Motivational interviewing for teens with gaming problems
This study tests a talking program (called motivational interviewing) that helps teens aged 10-16 who struggle with too much gaming. The goal is to help them build motivation to change their gaming habits.
ShatinAges 10–16 - NCT03945162RecruitingPhase 2
Bladder cancer trial using light therapy in the bladder
This Phase 2 study tests a treatment called photodynamic therapy (PDT) placed directly into the bladder. It may help people whose non–muscle-invasive bladder cancer did not respond to BCG treatment or could not tolerate it.
Chicago, IllinoisAges 18 years+ - NCT05903235Recruiting
VR and mirror therapy for arm recovery after stroke
This trial tests a mix of virtual reality (VR) and mirror therapy to help improve arm movement after a stroke. You may be asked to use the technology and give feedback, and the study may compare it with other care approaches to see if it helps more.
Taoyuan CityAges 20–80 - NCT05893888RecruitingPhase 2/Phase 3
Testing three investigational drugs for mouth and lung cancers
This trial tests whether PRV111, PRV211, and PRV131 are safe and work better than expected for certain mouth (lip/oral cavity) cancers and lung cancers. It may help by trying a new approach given directly to the tumor and then monitoring how well it shrinks and how safe it is.
Duarte, CaliforniaAges 18–100 - NCT05897164Recruiting
Mobile app to help teens cut back on substance use
This study tests a mobile app designed to help teens who use alcohol or drugs cut back or stop. You and your teen would use the app together and get support from the study team by text.
Baltimore, MarylandAges 13 years+ - NCT05877300RecruitingPhase 1
Test a new esophagus implant to rebuild a short esophagus segment
This Phase 1 study tests the safety and feasibility of a new esophagus implant for people who need only a short (about 6 cm or less) section of their esophagus rebuilt after serious injury or scarring. If it does not work, you must be willing to have a planned “rescue” surgery later.
Los Angeles, CaliforniaAges 18 years+ - NCT05865002RecruitingPhase 1
Safety and drug test for AUR107 in advanced cancers
This early-phase study tests whether AUR107 is safe and may help shrink or control advanced solid tumors that have come back or progressed. You may be considered if standard treatments no longer work and you meet specific blood, organ, and health requirements.
Vijayawada, Andhra PradeshAges 18 years+ - NCT05876000Recruiting
Heart pump study for very severe heart failure
This trial tests a left ventricular assist system (a mechanical heart pump for the left side of the heart) in people with very severe heart failure. It may help people who are too sick or not improving despite best available medical treatment.
GrazAges 18–75 - NCT05847894Recruiting
AI eye scans to help diagnose lung breathing problems
This trial tests an artificial intelligence (AI) tool that uses eye images to help doctors diagnose breathing or lung-related conditions. If you have a lung/breathing problem and can do both eye and lung checkups, it may support faster or more accurate diagnosis.
Guangzhou, GuangdongAges Any age - NCT05864547Recruiting
Study risk factors for seizures after a first stroke
This study looks at what factors can make seizures happen after a first stroke. It may help doctors identify who is more at risk so future care can be better targeted.
TrondheimAges 18–85 - NCT05875740Recruiting
Memory T cells and sepsis severity study
This study looks at a type of immune cell called 'memory CD8+ T cells' in patients with sepsis, a life-threatening response to infection. The goal is to see if these cells are linked to how severe the sepsis is and the risk of dying. This may help doctors better predict outcomes for people with sepsis.
Wuhan, HubeiAges 18–60 - NCT05236465Recruiting
3-day course for CFS/ME to help you manage symptoms
This trial tests whether a short, structured 3-day course can help people with CFS/ME (myalgic encephalomyelitis/chronic fatigue syndrome) through education and support for symptom management. It may be most helpful if you can currently step back from work or school and are ready to try changes.
TrondheimAges 18–65 - NCT05819944Recruiting
LUNG-TECH trial testing new tools to diagnose asthma
This trial studies new technologies to help doctors diagnose asthma and better understand airway inflammation. It may help you (or healthy volunteers, if eligible) by allowing your breathing tests and inflammation markers to be measured with newer diagnostic tools.
Portsmouth, HampshireAges 17 years+ - NCT05847179RecruitingPhase 2
Treating bone weakness in Werner syndrome
This study tests an investigational drug for people with Werner syndrome who have weak bones (osteopenia or osteoporosis). The goal is to see if the drug is safe and can help improve bone health.
Ann Arbor, MichiganAges 18 years+ - NCT05833555Recruiting
Harlem Strong mental health support for adults
This program is for Black and Latino adults in Harlem who are dealing with mild to moderate depression symptoms. It aims to identify people who may benefit from mental health support and connect them with the right level of care.
New York, New YorkAges 18–65 - NCT05809713Enrolling by invitation
Heart to Heart program to better control high blood pressure
This trial tests a “Heart to Heart” program using regular check-ins (including cell-based monitoring) to help lower high blood pressure. It’s for adults who have had blood pressure that stays too high even with usual care.
Greenville, North CarolinaAges 19 years+ - NCT05807841Recruiting
AI ultrasound during stent placement in heart artery blockages
This trial tests an artificial-intelligence tool that uses a heart ultrasound to help guide stent treatment. It may help doctors choose the best way to treat blockages and improve stent results for people with symptoms from reduced blood flow to the heart.
Bucheon-siAges 19 years+ - NCT05773820RecruitingPhase 1/Phase 2
Testing WJB001 capsules for advanced solid tumors
This early-phase study tests whether WJB001 capsules can treat advanced solid tumors in adults whose cancer has progressed after standard treatment (or who cannot take standard treatment). It also studies side effects and whether the drug can work for certain tumor types and genetic markers.
Beijing, Beijing MunicipalityAges 18 years+
Hear when a new Technology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for technology?
- Yes. Clin2 currently lists 1,080 recruiting technology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a technology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a technology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.